Efficacy and Safety of Qizhitongluo Capsule in the Recovery Phase of Ischemic Stroke
Status:
Completed
Trial end date:
2016-10-01
Target enrollment:
Participant gender:
Summary
This is a 20-week study consisting of a 12-week multicenter, randomized,double-blind adaptive
study to compare efficacy and safety of Qizhitongluo Capsule,Naoxintong Capsule and placebo
in the recovery phase of ischemic stroke with qi deficiency and blood stasis syndrome, and a
8-week post-treatment safety follow-up.After 312 patients complete 12 weeks of treatment
there will be an interim analysis.